About Enhancer

Enhancer ID: E_01_0966
Species: human
Position : chr13:27917232-27919232
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Insulinoma
Pubmed ID:  33060578
Enhancer experiment: PCR
Enhancer experiment description: NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation.

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation.

About TF

TF name : PDX1(GSF,IDX-1,IPF1,IUF1,MODY4,PAGEN1,PDX-1,STF-1)
TF experiment: PCR
TF experiment description: NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation.

About Function

Enhancer function : NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
PDX1 FOXA2 and FOXA3 transcription factor networks pid 45
PDX1 Regulation of gene expression in beta cells reactome 17
PDX1 Regulation of gene expression in early pancreatic precursor cells reactome 8
PDX1 Type II diabetes mellitus kegg 44
PDX1 Maturity onset diabetes of the young kegg 25

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs